Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm
- PMID: 25441768
- DOI: 10.1016/j.annemergmed.2014.09.012
Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm
Abstract
Study objective: Although the management and outcomes of emergency department (ED) patients with atrial fibrillation or flutter have been explored, such studies have typically excluded patients with acute underlying medical illnesses. We seek to describe the ED treatment and outcomes of these complex patients with atrial fibrillation or flutter.
Methods: This retrospective descriptive cohort study used an ECG database from 2 urban EDs to identify consecutive ED patients with an ECG demonstrating atrial fibrillation or flutter from January 1, 2009, to December 31, 2009. We categorized patients with atrial fibrillation or flutter as "complex" according to prespecified criteria and then grouped them as being managed with rate or rhythm control attempts, or not. The primary outcome was safety of rate or rhythm control, measured by whether patients had a predefined adverse event or not. The secondary outcome was the success of rate or rhythm control, defined as rate control decreasing the pulse rate by 20 beats/min and successful rhythm control, both within 4 hours of treatment initiation. Descriptive statistics were used to compare the 2 groups.
Results: Four hundred sixteen complex patients with atrial fibrillation or flutter were identified. Patients managed with rate or rhythm control were similar in all baseline characteristics and illness distribution to patients who were not managed in this manner. The 135 patients with attempted rate control (105) or rhythm control (30) had 55 adverse events (40.7%; 95% confidence interval [CI] 32.5% to 49.5%), whereas the 281 patients not managed with rate or rhythm control had 20 adverse events (7.1%; 95% CI 4.5% to 10.9%), for a risk difference of 33.6% (95% CI 24.3% to 42.5%) and a relative risk of 5.7 (95% CI 3.6 to 9.1). Twenty of 105 patients (19.1%; 95% CI 12.3% to 28.1%) were successfully rate controlled, whereas 4 of 30 (13.3%; 95% CI 4.4% to 31.6%) were successfully rhythm controlled.
Conclusion: In ED patients with complex atrial fibrillation or flutter, attempts at rate and rhythm control are associated with a nearly 6-fold higher adverse event rate than that for patients who are not managed with rate or rhythm control. Success rates of rate or rhythm control attempts appear low.
Copyright © 2014 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
Comment in
-
Patient Selection Is Critical in Rate or Rhythm Control of Atrial Fibrillation or Flutter.Ann Emerg Med. 2015 Nov;66(5):562-3. doi: 10.1016/j.annemergmed.2015.07.002. Ann Emerg Med. 2015. PMID: 26497439 No abstract available.
-
In reply.Ann Emerg Med. 2015 Nov;66(5):563-5. doi: 10.1016/j.annemergmed.2015.07.003. Ann Emerg Med. 2015. PMID: 26497440 No abstract available.
-
Cardiovascular Critical Care: Therapeutic Hypothermia, Atrial Fibrillation, and Cardiopulmonary Resuscitation.Am J Respir Crit Care Med. 2016 Sep 15;194(6):762-4. doi: 10.1164/rccm.201601-0165RR. Am J Respir Crit Care Med. 2016. PMID: 27414431 No abstract available.
Similar articles
-
The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department.Eur J Emerg Med. 2015 Jun;22(3):155-61. doi: 10.1097/MEJ.0000000000000198. Eur J Emerg Med. 2015. PMID: 25203594
-
Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals.Ann Emerg Med. 2017 May;69(5):562-571.e2. doi: 10.1016/j.annemergmed.2016.10.013. Epub 2017 Jan 19. Ann Emerg Med. 2017. PMID: 28110987
-
Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.Acad Emerg Med. 2007 Dec;14(12):1158-64. doi: 10.1197/j.aem.2007.07.016. Acad Emerg Med. 2007. PMID: 18045891
-
Pharmacological cardioversion for atrial fibrillation and flutter.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003713. doi: 10.1002/14651858.CD003713.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2017 Nov 15;11:CD003713. doi: 10.1002/14651858.CD003713.pub3. PMID: 15846675 Updated. Review.
-
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department.Can J Cardiol. 2011 Jan-Feb;27(1):38-46. doi: 10.1016/j.cjca.2010.11.014. Can J Cardiol. 2011. PMID: 21329861
Cited by
-
Telemedicine Consult for Shortness of Breath Due to Sympathetic Crashing Acute Pulmonary Edema.J Educ Teach Emerg Med. 2023 Jan 31;8(1):S1-S24. doi: 10.21980/J8HS86. eCollection 2023 Jan. J Educ Teach Emerg Med. 2023. PMID: 37465040 Free PMC article.
-
Clinical decision support to Optimize Care of patients with Atrial Fibrillation or flutter in the Emergency department: protocol of a stepped-wedge cluster randomized pragmatic trial (O'CAFÉ trial).Trials. 2023 Mar 31;24(1):246. doi: 10.1186/s13063-023-07230-2. Trials. 2023. PMID: 37004068 Free PMC article.
-
Heart failure and atrial flutter: a systematic review of current knowledge and practices.ESC Heart Fail. 2021 Dec;8(6):4484-4496. doi: 10.1002/ehf2.13526. Epub 2021 Sep 10. ESC Heart Fail. 2021. PMID: 34505352 Free PMC article. Review.
-
Just the facts: Atrial fibrillation or flutter in patients who are candidates for rate control.CJEM. 2021 Jul;23(4):437-440. doi: 10.1007/s43678-021-00116-9. Epub 2021 Mar 25. CJEM. 2021. PMID: 33765287 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
